bs-16284R [Primary Antibody]
GPR107 Polyclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: GPR107

Immunogen Range: 301-400/600


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 57720

Swiss Prot: Q5VW38

Source: KLH conjugated synthetic peptide derived from human GPR107

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.

Background:

Involved in Golgi-to-ER retrograde transport. Functions as a host factor required for infection by Pseudomonas aeruginosa exotoxin A and Campylobacter jejuni CDT toxins.

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
ELISA(1:500-1000)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)
ICC(1:100-500)

Predicted Molecular Weight: 63


Cross Reactive Species: Human
Mouse

Predicted Cross Reactive Species: Rat
Dog
Horse
Chicken
Rabbit

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Mariami Jasaszwili. et al. The effects of neuronostatin on proliferation and differentiation of rat primary preadipocytes and 3T3-L1 cells. Bba-Mol Cell Biol L. 2021 Nov;1866:159018Read more>>
VALIDATION IMAGES

A549 lysates probed with GPR107 Polyclonal Antibody, Unconjugated (bs-16284R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.


Lane 1: Mouse Cerebrum tissue lysates; Lane 2: Mouse Cerebellum tissue lysates; Lane 3: Rat Cerebrum tissue lysates; Lane 4: Rat Cerebellum tissue lysates; Lane 5: Human PANC-1 cell lysates; Lane 6: Human HeLa cell lysates; Lane 7: Human SH-SY5Y cell lysates; Lane 8: Human A549 cell lysates; Lane 9: Human HUVEC cell lysates; Lane 10: Human Jurkat cell lysates probed with GPR107 Polyclonal Antibody, Unconjugated (bs-16284R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.